Abeona Therapeutics (ABEO) Net Margin (2011 - 2026)

Abeona Therapeutics' Net Margin history runs 13 years deep, the most recent figure standing at 195.81% for Q1 2026.

• In Q1 2026, Net Margin changed N/A year-over-year to 195.81%; the TTM figure through Mar 2026 stood at 481.03% (changed N/A YoY), while the FY2025 annual figure was 1152.53%, changed N/A from the prior year.
• Net Margin was 195.81% for Q1 2026 at Abeona Therapeutics, up from 396.48% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 28416.75% in Q2 2025 to a low of 10504.41% in Q4 2022.
• Historically, Net Margin has averaged 1435.34% across 4 years, with a median of 475.83% in 2023.
• Biggest YoY gain for Net Margin was 31207 bps in 2023; the steepest drop was 31207 bps in 2023.
• A 4-year view of Net Margin shows it stood at 10504.41% in 2022, then soared by 95 bps to 475.83% in 2023, then advanced by 17 bps to 396.48% in 2025, then jumped by 51 bps to 195.81% in 2026.
• The last three Net Margin figures came in at 195.81% (Q1 2026), 396.48% (Q4 2025), and 28416.75% (Q2 2025), per Business Quant data.